Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5. Eur J Cancer. 2017;77:140-52. [Šekerija M]
Autori: Dal Maso L,
Tavilla A,
Pacini F,
Serraino D,
van Dijk BAC,
Chirlaque MD,
Capocaccia R,
Larranaga N,
Colonna M,
Agius D,
Ardanaz E,
Rubió-Casadevall J,
Kowalska A,
Virdone S,
Mallone S,
Amash H,
De Angelis R,
EUROCARE-5 Working GroupGodina: 2017
Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study. Lancet Oncol. 2017;18(8):1022-39.[Šekerija M]
Autori: Gatta G,
Capocaccia R,
Botta L,
Mallone S,
De Angelis R,
Ardanaz E,
Comber H,
Dimitrova N,
Leinonen MK,
Siesling S,
van der Zwan JM,
Van Eycken L,
Visser O,
Žakelj MP,
Anderson LA,
Bella F,
Kaire I,
Otter R,
Stiller CA,
Trama A,
RARECAREnet working groupGodina: 2017
Epidemiology of rare cancers and inequalities in oncologic outcomes. Eur J Surg Oncol. 2017 Sep 19. pii: S0748-7983(17)30685-6. doi: 10.1016/j.ejso.2017.08.018. [Epub ahead of print] [Šekerija M]
Autori: Gatta G,
Trama A,
Capocaccia R,
RARECAREnet working groupGodina: 2017
(Šekerija M) Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999-2007: Results of EUROCARE-5. European journal of cancer. 2015.
Autori: Lepage C,
Capocaccia R,
Hackl M,
Lemmens V,
Molina E,
Pierannunzio DGodina: 2015
(Šekerija M) The EUROCARE-5 study on cancer survival in Europe 1999-2007: database, quality checks and statistical analysis methods. European Journal of Cancer. 2015.
Autori: Rossi S,
Baili P,
Capocaccia R,
Caldora M,
Carrani E,
Minicozzi PGodina: 2015
